ICON plc Stock News

ICON Public Limited Company is a leading clinical research organization, aiding researchers and companies across the entire industry in performing their work. The healthcare industry is extremely stro

Icon PLC (ICLR) possesses solid growth attributes, which could help it handily outperform the market.

Icon PLC (ICLR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Icon PLC (ICLR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

CRK, MATX, RGP, ESTE, and ICLR have been added to the Zacks Rank #1 (Strong Buy) List on July 26, 2021.

ICLR, DG, AN, and DVN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 26, 2021

ICON Public Limited Company (ICLR) CEO Steve Cutler on Q2 2021 Results - Earnings Call Transcript

Icon PLC (ICLR) delivered earnings and revenue surprises of 0.95% and 2.92%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

DUBLIN,--(BUSINESS WIRE)--ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting

Icon PLC (ICLR) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

New Strong Buy Stocks for July 8th

Icon PLC (ICLR) could produce exceptional returns because of its solid growth attributes.

Icon PLC (ICLR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in

DUBLIN--(BUSINESS WIRE)--ICON acquisition creates world-leading healthcare intelligence and clinical research organisation